IPHA FINAL DEADLINE NOTICE: ROSEN, LEADING INVESTOR COUNSEL, Reminds Innate Pharma S.A. Investors of Important Tuesday Deadline in Securities Class Action - IPHANewsfile Corp • 12/21/20
IPHA Deadline Alert: Rosen, A Trusted and Top Ranked Law Firm, Reminds Innate Pharma S.A. Investors of Important December 22 Deadline in Securities Class Action - IPHANewsfile Corp • 12/19/20
DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Innate Pharma S.A.Business Wire • 12/19/20
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Innate Pharma SA (IPHA)Business Wire • 12/18/20
ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Reminds Innate Pharma S.A. Investors of Important December 22 Deadline in Securities Class Action - IPHAPRNewsWire • 12/15/20
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Innate Pharma SA (IPHA)PRNewsWire • 12/14/20
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Innate Pharma S.A. - IPHAGlobeNewsWire • 12/13/20
Zhang Investor Law Reminds Innate Pharma S.A. Investors with Losses of December 22 Deadline in Securities Class Action – IPHAGlobeNewsWire • 12/11/20
Innate Pharma to Return US and EU Lumoxiti Commercialization Rights to AstraZenecaGlobeNewsWire • 12/11/20
Innate Pharma to return US and EU Lumoxiti commercialization rights to AstraZenecaGlobeNewsWire • 12/11/20
Rosen, Trusted National Trial Counsel, Reminds Innate Pharma S.A. Investors of Important December 22 Deadline in Securities Class Action - IPHANewsfile Corp • 12/09/20
Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Innate Pharma SA (IPHA)GlobeNewsWire • 12/09/20
LOOMING DEC. 22 DEADLINE Pawar Law Group Announces a Securities Class Action Lawsuit Against Innate Pharma S.A.GlobeNewsWire • 12/09/20
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Innate Pharma S.A. – IPHAGlobeNewsWire • 12/08/20
Rosen, A Leading and Longstanding Law Firm, Reminds Innate Pharma S.A. Investors of Important December 22 Deadline in Securities Class Action First Filed by Firm; Encourages Investors with Losses Exceeding $100K to Contact Firm - IPHANewsfile Corp • 12/07/20
Innate Pharma to Present Additional Efficacy Data for Monalizumab in Combination With Cetuximab in Head and Neck Cancer at the ESMO Immuno-Oncology Virtual CongressGlobeNewsWire • 12/03/20
ROSEN, A LEADING LAW FIRM, Reminds Innate Pharma S.A. Investors of Important December 22 Deadline in Securities Class Action; Encourages Investors with Losses Exceeding $100K to Contact the Firm - IPHAPRNewsWire • 12/02/20
UPCOMING DEC. 22 DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Innate Pharma S.A.GlobeNewsWire • 11/26/20
ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Reminds Innate Pharma S.A. Investors of Important December 22 Deadline in First Filed Securities Class Action Commenced by the Firm; Encourages Investors with Losses Exceeding $100K to Contact Firm - IPHANewsfile Corp • 11/23/20
Innate Pharma reports third quarter 2020 financial results and business updateGlobeNewsWire • 11/17/20
ROSEN, A TOP RANKED LAW FIRM, Reminds Innate Pharma S.A. Investors of Important December 22 Deadline in First Filed Securities Class Action Commenced by the Firm; Encourages Investors with Losses Exceeding $100K to Contact Firm - IPHAPRNewsWire • 11/14/20
Innate Pharma Receives Prime Designation From the European Medicines Agency for Lacutamab in Sézary SyndromeGlobeNewsWire • 11/13/20
ROSEN, A TOP RANKED LAW FIRM, Reminds Innate Pharma S.A. Investors of Important December 22 Deadline in First Filed Securities Class Action Commenced by the Firm; Encourages Investors with Losses in Excess of $100K to Contact the Firm - IPHANewsfile Corp • 11/09/20
ROSEN, RESPECTED INVESTOR COUNSEL, Reminds Innate Pharma S.A. Investors of Important December 22 Deadline in First Filed Securities Class Action Commenced by the Firm - IPHANewsfile Corp • 11/07/20